SalviaSanjayJainMD

PubMed

• Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-...
  Brian Estrella, Mark M Francescone, Yun Kyoung Ryu Tiger, Salvia Jain, Stefan K Barta, Seda Tolu, Ahmed Sawas, Jennifer K Lue, Barbara Pro, Jennifer E Amengual> ;Leukemia & Lymphoma. 2024 Mar 22
• KLRG1 Cell Depletion As A Novel Therapeutic Strategy In Patients With Mature T-cell lymphoma Subtypes.
  Assatova, B., Willim, R., Trevisani, C., Haskett, G., Kariya, K., Chopra, K., Park, S., Tolstorukov, M., McCabe, S., Duffy, J., Louissaint, A., Huuhtanen, J., Bhattach...> ;Clinical Cancer Research. 2024 Jan 22
• 1 citations
  TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
  Gongwei Wu, Noriaki Yoshida, Jihe Liu, Xiaoyang Zhang, Yuan Xiong, Tayla B Heavican-Foral, Elisa Mandato, Huiyun Liu, Geoffrey M Nelson, Lu Yang, Renee Chen, Katherine...> ;Science Translational Medicine. 2023 Sep 20
• 3 citations
  PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.
  Tim Wartewig, Jay Daniels, Miriam Schulz, Erik Hameister, Abhinav Joshi, Joonhee Park, Emma Morrish, Anuroop V Venkatasubramani, Filippo M Cernilogar, Frits H A van He...> ;Nature Cancer. 2023 Oct 1
• Prevalence of autoimmune diseases in cutaneous B-cell lymphoma: A retrospective cross sectional analysis.
  David Xiang, Katherine Perlman, Bethany Brumbaugh, Rachel Reardon, Jeffrey Barnes, Chirayu Patel, Salvia Jain, Steven T Chen> ;Journal of the American Academy of Dermatology. 2024 Jan 1
• 1 citations
  Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma.
  Matko Kalac, Salvia Jain, Constantine S Tam, Zhengrui Xiao, Francesca Montanari, Jennifer Kanakry, Bryan D Huber, Mendel Goldfinger, Owen A O'Connor, Enrica Marchi> ;Blood Advances. 2023 Jul 25
• 1 citations
  Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis.
  Nazila Shafagati, Min J Koh, Leora Boussi, Hyun J Park, Robert Stuver, Paul Bain, Francine M Foss, Changyu Shen, Salvia Jain> ;Blood Advances. 2022 Aug 23
• 9 citations
  Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.
  Wenchao Wu, Geoffrey M Nelson, Raphael Koch, Katherine A Donovan, Radosław P Nowak, Tayla B Heavican-Foral, Ajit J Nirmal, Huiyun Liu, Lei Yang, Jessica Duffy, Foster ...> ;Blood. 2022 Mar 31
• Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas.
  Min Jung Koh, Mwanasha H Merrill, Min Ji Koh, Robert Stuver, Carolyn D Alonso, Francine M Foss, Angel M Mayor, John Gill, Marta Epeldegui, Edward Cachay, Jennifer E Th...> ;Blood Advances. 2022 Mar 8
• 35 citations
  Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas.
  Salvia Jain, Alexandria Van Scoyk, Elizabeth A. Morgan, Andrew Matthews, Kristen E. Stevenson, Gail Newton, Foster Powers, Anu Autio, Abner Louissaint, Guillemette Pon...> ;Blood. 2019 Oct 24
• 21 citations
  Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell...
  Robert Stuver, Niloufer Khan, Marc Schwartz, Mark Acosta, Massimo Federico, Christian Gisselbrecht, Steven M. Horwitz, Frederik Lansigan, Lauren C. Pinter-Brown, Barba...> ;American Journal of Hematology. 2019 Jun 1
• 45 citations
  Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
  Myrna Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia Rachel Pyzer, Eleni Anastasiadou, Anna Sergeeva, Adam Ephraim, Abigail Washington, Shira Orr, ...> ;British Journal of Haematology. 2019 Mar 3
• 13 citations
  DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.
  Rebecca Karp Leaf, Dina Stroopinsky, Ada M. Kruisbeek, Sandra van Wetering, Abigail Washington, Adam Ephraim, Leandra Cole, Adam Morin, Salvia Jain, Myrna Nahas, Arik ...> ;Journal of Immunotherapy. 2017 Nov 1
• 11 citations
  Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma
  Salvia Jain, Abigail Washington, Rebecca Karp Leaf, Parul Bhargava, Rachael A. Clark, Thomas S. Kupper, Dina Stroopinsky, Leandra Cole, Myrna Nahas, Arie Apel, Jacalyn...> ;Molecular Cancer Therapeutics. 2017 Oct 1
• 53 citations
  MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs
  , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2017 May 30
• 19 citations
  Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1
  Michal Bar-Natan, Dina Stroopinsky, Katarina Luptakova, Maxwell D. Coll, Arie Apel, Hasan Rajabi, Athalia Rachel Pyzer, Kristen Palmer, Michaela R. Reagan, Myrna Nahas...> ;British Journal of Haematology. 2017 Jan 20
• 115 citations
  MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
  Athalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, Abigail Washington, Ashujit Tagde, Maxwell D. Coll, Jacqueline Fung, Mary Paty Bryant, Leandra Cole, Kristen Palm...> ;Blood. 2017 Mar 30
• 119 citations
  Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
  Jacalyn Rosenblatt, Richard Stone, Lynne Uhl, Donna Neuberg, Robin Joyce, James D. Levine, Jon E. Arnason, Malgorzata McMasters, Katarina Luptakova, Salvia Jain, Jeffr...> ;Science Translational Medicine. 2016 Dec 7
• 24 citations
  Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
  , , , , , , , , , , , , , , , , , , , , , , , , , > ;Blood. 2016 Dec 2
• 41 citations
  Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma
  Salvia Jain, Xavier Jirau-Serrano, Kelly Zullo, Luigi Scotto, Carmine F. Palermo, Stephen A. Sastra, Kenneth P. Olive, Serge Cremers, Tiffany Thomas, Ying Wei, Yuan Zh...> ;Clinical Cancer Research. 2015 May 1
• 1 citations
  B-cell lymphoma of the vagina occurring after treatment for classic Hodgkin lymphoma: a case report and literature review.
  Xiaowei Chen, Diane Hamele-Bena, Kar Fai Chow, Melanie Hawver, C T Huangjun He, Bruce Raphael, Salvia Jain, Thomas C. Wright> ;Diagnostic Cytopathology. 2013 May 1
• 40 citations
  Novel therapeutic agents for cutaneous T-Cell lymphoma
  Salvia Jain, Jasmine Zain, Owen A. O'Connor> ;Journal of Hematology & Oncology. 2012 May 17
• 58 citations
  CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
  Jonathan A. Harris, Salvia Jain, Qinghu Ren, Alirezah Zarineh, Cynthia Liu, Sherif Ibrahim> ;Diagnostic Pathology. 2012 Jan 30
• 41 citations
  Romidepsin in the treatment of cutaneous T-cell lymphoma
  Salvia Jain, Jasmine Zain> ;Journal of Blood Medicine. 2011 Apr 4
• 35 citations
  Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma.
  Salvia Jain, Catherine Diefenbach, Jasmine Zain, Owen A. O'Connor> ;Core Evidence. 2011 Apr 4
• Join now to see all

Abstracts/Posters

• Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma
  Salvia Jain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018